期刊文献+

维持性血液透析患者病毒性肝炎感染分析 被引量:11

Analysis of virus hepatitis infection in maintenance hemodialysis patients
在线阅读 下载PDF
导出
摘要 目的了解维持性血液透析患者病毒性肝炎感染情况及危险因素,探讨预防血液透析患者感染病毒性肝炎的措施。方法对2009~2011年中国医科大学附属第一医院肾内科血液透析室的125例维持性血液透析患者,采用化学发光法检测丙型肝炎病毒(HCV)抗体及乙型肝炎6项,回顾分析维持性血液透析患者的临床资料。结果 125例维持性血液透析患者肝炎病毒感染率分别为乙型肝炎病毒(HBV)23.2%,丙型肝炎病毒5.6%。不同年龄和性别在病毒性肝炎感染率差异无显著性(P>0.05),HBV感染组、非感染组在输血次数差异无显著性(P>0.05),在透析时间差异具有显著性(HBV感染组60.1±25.7月比非感染组43.0±25.3月,P<0.01)。HCV感染组、非感染组在输血次数(HCV感染组85.7%vs.非感染组15.7%,P<0.05)、透析年限(HCV感染组65.9±35.9月比非感染组43.0±25.3月,P<0.05)的差异均有显著性。结论血液透析患者是肝炎病毒感染的高危人群,乙型肝炎感染率在输血次数的差异无显著性,与透析年限的差异有显著性,丙型肝炎感染率随输血次数及血液透析时间的延长而增高。严格隔离可以预防医院内交叉感染的发生。 Objective To observe the prevalence of virus hepatitis infection in maintenance hemodialysis (MHD) patients, and to investigate the methods to prevent and control virus hepatitis infection in dialysis unit. Methods A total of 6 assays for the detection of antibodies for HCV and antibodies and antigens for hepatitis B were performed by chemiluminescence immunoassay method in 125 MHD patients on regular hemodialysis for more than one year (2009-2011). Clinical data were analyzed retrospectively. Results The incidence of HBV hepatitis and HCV hepatitis in MHD patients were 23.2% and 5.6%, respectively, without significant correlation of the incidences with age or gender (P> 0.05). For HBV infection, there was no difference in blood transfusion times between positive infection group and negative infection group (P> 0.05), but there was significant difference in hemodialysis age between positive infection group and negative infection group (60.1±25.7 months in the former group, and 43.0±25.3 months in the latter group, P< 0.01). For HCV infection, positive infection group and negative infection group showed significant differences in blood transfusion times (85.7% in the former group, and 15.7% in the latter group, P < 0.05) and hemodialysis age (65.9±35.9 months in the former group and 43.0±25.3 months in the latter group, P < 0.05). Conclusion MHD patients are at high risk to infection of hepatitis viruses. The incidence of HBV infection increases in MHD patients with longer hemodialysis age, but seems to be unrelated to blood transfusion times. The chance of HCV infection increases in patients with multiple blood transfusion and longer hemodialysis age. Strict isolation procedures must be carried out to prevent HBV and HCV cross-infection in dialysis unit.
出处 《中国血液净化》 2012年第8期417-420,共4页 Chinese Journal of Blood Purification
关键词 血液透析 乙型肝炎病毒 丙型肝炎病毒 交叉感染 Hemodialysis Hepatitis B virus Hepatitis C virus Cross-infection
  • 相关文献

参考文献4

二级参考文献55

  • 1Shaheen FA, Huraib SO, Al-Rashed R, et al. Prevalence of hepatitis C antibodies among hemodialysis patients in Jeddah area, Saudi Arabia.Saudi Med J, 2003, 2:S125-126.
  • 2Fabrizi F, Martin P, Dixit V, et al. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.Am J Kidney Dis, 2000, 35:122-129.
  • 3Caramele C. Undiagnosed hepatitis C virus infection in hemodialysispatients:Value of HCVRNAand live enzyme levels.Kidney Int, 1996,50(6):2027-2037.
  • 4Ghany MG, Kleiner DE, Alter H, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology, 2003,124:97-104.
  • 5Espinosa M, Martin-Malo A, Alvarez-de-lara MA, et al. Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant, 2001, 16(8): 1669-1674.
  • 6Espinosa M, Martin-Malo A, Alvarez-de-lara MA, et al. Natural history of acute HCV infection in hemodialysis patients.Clin Nephrol, 2002,55:143-150.
  • 7Stehman-Breen CO, Emerson S, Gretch D, et al. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kindey Dis, 1998,32:629-634.
  • 8Locatelli F, Marcelli D, Conte F, et al. Cardiovascular disease in chronic renal failure:the challenge continues.Nephrol Dial Transplant, 2000, 15:69-80.
  • 9Nakayama E, Akiba T, Marnmo F, et al. Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol, 2000,11:1896-1902.
  • 10Okamoto H, Okatla S, Sugiyama Y, et al. The 5 terminal sequence of the hepatitis C virus genome. Jpn J Exp, 1997,69:167-177.

共引文献144

同被引文献129

引证文献11

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部